Key result
Various non-mutually exclusive pathogenetic mechanisms, including inflammatory, apoptotic, and genetic factors such as desmosomal mutations, appear to underlie arrhythmogenic right ventricular cardiomyopathy.
This review highlights that ARVC pathogenesis is multifactorial, involving both traditional inflammatory/apoptotic pathways and genetic mechanisms like desmosomal mutations.
Answers are grounded in this paper and cite their sources.
ARVC pathogenesis appears multifactorial; leaves open mechanism-specific therapies pending prospective validation.
Arrhythmogenic right ventricular cardiomyopathy (ARVC), a predominantly familial and autosomal dominant inherited heart muscle disorder, is pathologically characterized by progressive right ventricular myocardial atrophy and fibrofatty replacement and clinically by ventricular arrhythmias with left bundle branch block morphology. Symptoms poorly reflect disease severity, with disease commonly first manifesting as sudden death among the young. The inflammatory and apoptotic theories first put forth to explain ARVC pathogenesis do not explain all cases, and advances in genetic technology have allowed to elucidate genetic mechanisms, with desmosomal mutations attracting much attention. As reviewed here, various non-mutually exclusive pathogenetic mechanisms therefore appear to underlie ARVC.
No takes yet. Share an insight, caveat, or question.
Que et al. (2015) conducted a review in Arrhythmogenic right ventricular cardiomyopathy (ARVC). Traditional vs. genetic pathogenesis was evaluated. Various non-mutually exclusive pathogenetic mechanisms, including inflammatory, apoptotic, and genetic factors such as desmosomal mutations, appear to underlie arrhythmogenic right ventricular cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: